Oscor receives CE Mark, FDA, and Health Canada clearance on its Breezeway II next generation transseptal access delivery system. Available in inner diameter sheath sizes ranging from 6F to 14F and with various length and curve configurations. The Breezeway II delivery system features a fully integrated valve bypass and device loader system.
The Breezeway II delivery system is designed to allow streamlined and controlled delivery of complex devices via transseptal access to the left side of the heart, while providing complete hemostasis. Ideally suited for minimal invasive electrophysiology and structural heart applications, the Breezeway II integrated delivery system is available immediately under Oscor and OEM branding.
For more information, please contact our product specialists at sales@oscor.com